Unilever Accelerates Q4 Pricing

Unilever is walking a tightrope—raising prices again to offset rising costs, but struggling to keep sales volumes growing in North America and Europe. While overall Q3 turnover climbed to €13.3 billion, developed markets are stumbling, with North America sales down 0.7% and Europe off 1.7%. The bright spot: emerging markets like India, Turkey, and Vietnam, where sales are surging, helping offset softness in the West. The stakes? If price hikes outpace shoppers’ willingness to pay, Unilever risks handing market share to cheaper rivals or private-label brands.

But here’s the catch: CEO Fernando Fernández is signaling another round of price increases into 2027, blaming fresh cost pressures tied to global instability. That’s risky business when U.S. demand is already sluggish and promotions are heating up. Meanwhile, Unilever is slimming down its portfolio—progressing on a big foods divestment tied to McCormick—even as it leans harder on beauty and wellbeing for growth. The India business is booming, but even there, warning signs are flashing: commodity inflation, regulatory headwinds, and rural demand risks could squeeze margins ahead.

Talent drama adds another twist. Unilever just lost exec Fabian Garcia to rival Clorox as North American results falter—raising questions about leadership depth and its ability to recover share in key markets. Reporting draws on insights from Unilever Global, The Economic Times, and WWD.

Powered by Apisod.com